CARB-X is the largest externally-funded program at Boston University reporting to the Vice President and Provost for Research. CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research and development to tackle the threat of drug-resistant bacteria. The CARB-X portfolio is the world’s most promising early development pipeline of innovative products to prevent, diagnose, and treat life-threatening bacterial infections. CARB-X is grant-funded and currently supported by multiple government and foundation funders. The CARB-X environment is innovative, dynamic, energetic, and rapidly evolving. The CARB-X Financial Operations Specialist is a member of the Finance & Research Administration team and oversees financial tasks and transactions on behalf of all teams.